These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3259894)
61. Late recurrence of Langerhans cell histiocytosis in the orbit. Escardó-Paton JA; Neal J; Lane CM Br J Ophthalmol; 2004 Jun; 88(6):838-9. PubMed ID: 15148227 [No Abstract] [Full Text] [Related]
62. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899 [TBL] [Abstract][Full Text] [Related]
63. Pseudotumor. Curtin HD Radiol Clin North Am; 1987 May; 25(3):583-99. PubMed ID: 3575690 [TBL] [Abstract][Full Text] [Related]
64. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence. Wei RL; Cheng JW; Cai JP Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177 [TBL] [Abstract][Full Text] [Related]
65. [Radiation therapy of Graves' ophthalmopathy]. Kawamura T; Koga S; Anno H; Komai S Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jan; 52(1):78-85. PubMed ID: 1549451 [TBL] [Abstract][Full Text] [Related]
67. [Report of a rare case of Langerhans-cell histiocytosis of the skull base]. Krengli M; Boccardi A; Gandini G; Negri G Minerva Med; 1996 Mar; 87(3):99-103. PubMed ID: 8668295 [TBL] [Abstract][Full Text] [Related]
68. Using fixed anatomical landmarks to avoid medial rectus injury: a radiographic analysis in patients with and without Graves' disease. Suh JD; Kuan EC; Thompson CF; Scawn RL; Feinstein AJ; Barham HP; Kingdom TT; Ramakrishnan VR Am J Otolaryngol; 2016; 37(4):334-8. PubMed ID: 27040416 [TBL] [Abstract][Full Text] [Related]
69. Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous? Bartalena L; Marcocci C; Gorman CA; Wiersinga WM; Pinchera A J Endocrinol Invest; 2003 Jan; 26(1):5-16. PubMed ID: 12602528 [TBL] [Abstract][Full Text] [Related]
71. [Treatment of Graves' ophthalmopathy with irradiation]. Slampa P; Spurný V; Seneklová Z; Krákorová D Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449 [TBL] [Abstract][Full Text] [Related]
72. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment. Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160 [TBL] [Abstract][Full Text] [Related]
73. Quantitative CT of the orbit in Graves' disease. Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341 [TBL] [Abstract][Full Text] [Related]
74. Multifocal soft tissue Langerhans' cell histiocytosis treated with PET-CT based conformal radiotherapy. Onal C; Oymak E; Reyhan M; Canpolat T; Ozyilkan O Jpn J Radiol; 2015 Sep; 33(9):603-6. PubMed ID: 26211006 [TBL] [Abstract][Full Text] [Related]
75. Letter: Orbital radiation in Graves' disease. Rubenzik R Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740 [No Abstract] [Full Text] [Related]
76. Irradiation of histiocytosis X confined to the oral mucosa. Schiebe M; Schroeder HG; Hoffmann W Strahlenther Onkol; 2001 Jan; 177(1):48-50. PubMed ID: 11200113 [TBL] [Abstract][Full Text] [Related]
77. CT characteristics of the normal pituitary gland. Brown SB; Irwin KM; Enzmann DR Neuroradiology; 1983; 24(5):259-62. PubMed ID: 6687631 [TBL] [Abstract][Full Text] [Related]
78. Clinical importance of radiotherapy in the treatment of Graves' disease. Friedrich A; Kamprad F; Goldmann A Front Radiat Ther Oncol; 1997; 30():195-205. PubMed ID: 9205902 [No Abstract] [Full Text] [Related]
79. Histiocytosis X: does radiotherapy still have a role? el-Sayed S; Brewin TB Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):27-31. PubMed ID: 1736975 [TBL] [Abstract][Full Text] [Related]